Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty

NCT00420277 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

462

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypotension
Ischemia

Interventions

DRUG: Hemospan (MP4OX)
DRUG: Voluven (HES 130/0.4)

Sponsor

Sangart